Mylan NV Return On Equity

MYL -- USA Stock  

Fiscal Quarter End: December 31, 2019  

Mylan NV return-on-equity fundamental analysis lookup allows you to check this and other indicators for Mylan NV or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Mylan NV Return On Equity Analysis

Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how effecently a company utilizes investments to generate income.
Return on Equity 
Net Income 
Total Equity 
More About Return On Equity | All Equity Analysis
Mylan NV Return On Equity  =
Mylan NV ValuationFundamentalsBuy or Sell

Mylan NV Return On Equity Over Time Pattern

 Mylan NV Return on Average Equity 

About Return On Equity

For most industries Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Compare to competition

Mylan NV Return On Equity Assessment

Shareholders Equity
Based on latest financial disclosure Mylan NV has Return On Equity of -1.0E-4%. This is 100.0% lower than that of the Healthcare sector, and significantly lower than that of Drug Manufacturers?Specialty & Generic industry, The Return On Equity for all stocks is 99.97% lower than the firm.

Did you try this?

Run Equity Forecasting Now


Equity Forecasting

Use basic forecasting models to generate price predictions and determine price momentum
All  Next Launch Module

Mylan NV current financial ratios